Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant522 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07530536 | rTMS for Postoperative Brain Tumor Patients | recruiting | N/A | 6 | Brian J.GillOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07532031 | APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas(APT-HGG) | not yet recruiting | — | 20 | IRCCS Ospedale San RaffaeleOTHER | 0 | Apr 15, 2026 | clinicaltrials |
| NCT02800486 | Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | recruiting | Phase 2 | 37 | Northwell HealthOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT04185038 | Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors | recruiting | Phase 1 | 90 | Seattle Children's HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05222620 | SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial | recruiting | Phase 2 | 90 | Mayo ClinicOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06599879 | Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention(IPANEMA) | recruiting | N/A | 130 | Institut Claudius RegaudOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06810544 | Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss | recruiting | Phase 1 / Phase 2 | 191 | Tango Therapeutics, Inc.INDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07505979 | SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases | not yet recruiting | Phase 2 | 90 | National Taiwan University HospitalOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT04569591 | DDAVP for Pituitary Adenoma | recruiting | N/A | 22 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Apr 9, 2026 | clinicaltrials |
| NCT06238882 | Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. | recruiting | N/A | 74 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07520370 | Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor | not yet recruiting | N/A | 1,370 | Beijing Tiantan HospitalOTHER | 0 | Apr 9, 2026 | clinicaltrials |
| NCT05286788 | MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | recruiting | Phase 2 | 38 | Nationwide Children's HospitalOTHER | 3 | Apr 8, 2026 | clinicaltrials |
| NCT07516353 | my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults | not yet recruiting | N/A | 143 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07481786 | Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases | recruiting | Phase 3 | 220 | Sun Yat-sen UniversityOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT04475640 | Cancer Genetic Testing in Ethnic Populations | recruiting | N/A | 1,800 | Mayo ClinicOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05819008 | Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries | recruiting | — | 350 | Umeå UniversityOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05267587 | Preop fSRS for Resectable Brain Metastases | active not recruiting | Phase 2 | 49 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 31, 2026 | clinicaltrials |
| NCT07499479 | Picture Naming Decoding From Intraoperative Recordings(Naming-Decoder) | not yet recruiting | N/A | 20 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT03605550 | A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma | active not recruiting | Phase 1 | 64 | Nationwide Children's HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06668519 | Magnetoencephalography in Children | recruiting | — | 1,500 | Children's Hospital of Fudan UniversityOTHER | 1 | Mar 25, 2026 | clinicaltrials |
| NCT00599092 | Pituitary Tumor Surveillance: Pathogenic Correlation | recruiting | — | 1,250 | Cedars-Sinai Medical CenterOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03610906 | Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy | enrolling by invitation | — | 250 | University of Colorado, DenverOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT02852655 | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma | active not recruiting | Phase 1 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06165653 | Guided Meditation During Radiation Therapy for Brain Tumors(Med-RT) | recruiting | N/A | 30 | University of UtahOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05733572 | Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG)(NGF-OPG) | active not recruiting | Phase 2 | 36 | Benedetto FalsiniOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06229483 | The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies | recruiting | Phase 3 | 102 | Stephen LownieOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06352710 | Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment | recruiting | — | 400 | Cantonal Hospital of St. GallenOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT02375841 | Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers | active not recruiting | — | 309 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT03478462 | Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas(CLOVER-2) | active not recruiting | Phase 1 | 30 | Cellectar Biosciences, Inc.INDUSTRY | 3 | Mar 18, 2026 | clinicaltrials |
| NCT04189172 | MiDura-Study (Neuro-Patch in Duraplasty)(MiDura) | active not recruiting | — | 328 | Aesculap AGINDUSTRY | 2 | Mar 18, 2026 | clinicaltrials |
| NCT04655404 | A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | recruiting | Early Phase 1 | 15 | Nationwide Children's HospitalOTHER | 5 | Mar 18, 2026 | clinicaltrials |
| NCT04943848 | rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG | recruiting | Phase 1 | 36 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT03665064 | Long Term Outcome Study in Patients With Pituitary Disorders | active not recruiting | — | 1,500 | University of AlbertaOTHER | 0 | Mar 16, 2026 | clinicaltrials |
| NCT07463235 | Safety and Potency of a High Cabergoline Dosage in Microprolactinomas(SPARAGMOS) | recruiting | Phase 3 | 70 | University of Sao Paulo General HospitalOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT07471100 | Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS) | not yet recruiting | N/A | 63 | Azienda Sanitaria dell'Alto AdigeOTHER | 0 | Mar 13, 2026 | clinicaltrials |
| NCT07468370 | Real Time Craniotomy Planning Using Mixed Reality | not yet recruiting | — | 54 | Brainlab AGINDUSTRY | 1 | Mar 12, 2026 | clinicaltrials |
| NCT03067467 | Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)(HPCIM) | recruiting | — | 25 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07063693 | ABY-029 Glioma Trial | recruiting | Phase 1 | 33 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07460037 | Chinese-Specific Speech Imagery Coding Using High-Density ECoG | recruiting | N/A | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05076513 | Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma | active not recruiting | Early Phase 1 | 42 | Nader SanaiOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT05859659 | Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE) | recruiting | — | 70,000 | Yaou LiuOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT07456878 | Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas | recruiting | Phase 1 | 5 | Mayo ClinicOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT05559853 | Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment | recruiting | — | 119 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study(MOMENTUM) | recruiting | — | 8,000 | UMC UtrechtOTHER | 9 | Mar 5, 2026 | clinicaltrials |
| NCT04197297 | Brain Imaging Biomarkers in Patients With Brain Metastasis | recruiting | Phase 2 | 90 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04244019 | FLT-PET / MRI Brain Mets | active not recruiting | — | 30 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04510051 | CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children | recruiting | Phase 1 | 18 | City of Hope Medical CenterOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04661384 | Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma | active not recruiting | Phase 1 | 10 | City of Hope Medical CenterOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT03152318 | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2(rQNestin) | active not recruiting | Phase 1 | 62 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 4, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Apr 15, 2026source: clinicaltrials